ATE236653T1 - Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen - Google Patents

Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen

Info

Publication number
ATE236653T1
ATE236653T1 AT98500119T AT98500119T ATE236653T1 AT E236653 T1 ATE236653 T1 AT E236653T1 AT 98500119 T AT98500119 T AT 98500119T AT 98500119 T AT98500119 T AT 98500119T AT E236653 T1 ATE236653 T1 AT E236653T1
Authority
AT
Austria
Prior art keywords
treatment
calcium channel
cardiovascular diseases
converting enzyme
enzyme inhibitors
Prior art date
Application number
AT98500119T
Other languages
English (en)
Inventor
Escude Luis Manuel Micheto
Duarte Joaquin Anto Delgadillo
Pedro Canovas
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8299270&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE236653(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Application granted granted Critical
Publication of ATE236653T1 publication Critical patent/ATE236653T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT98500119T 1997-05-13 1998-05-12 Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen ATE236653T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009701017A ES2125198B1 (es) 1997-05-13 1997-05-13 Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.

Publications (1)

Publication Number Publication Date
ATE236653T1 true ATE236653T1 (de) 2003-04-15

Family

ID=8299270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98500119T ATE236653T1 (de) 1997-05-13 1998-05-12 Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen

Country Status (23)

Country Link
EP (1) EP0884054B9 (de)
JP (1) JP3576806B2 (de)
CN (1) CN1146418C (de)
AR (1) AR011730A1 (de)
AT (1) ATE236653T1 (de)
AU (1) AU735404B2 (de)
BR (1) BR9805597A (de)
CA (1) CA2234899C (de)
CZ (1) CZ292616B6 (de)
DE (1) DE69813083T2 (de)
DK (1) DK0884054T3 (de)
ES (2) ES2125198B1 (de)
HU (1) HUP9801075A3 (de)
IL (1) IL124253A (de)
NO (1) NO315545B1 (de)
NZ (1) NZ330447A (de)
PL (1) PL192117B1 (de)
PT (1) PT884054E (de)
RU (1) RU2182002C2 (de)
SK (1) SK284337B6 (de)
TR (1) TR199800847A3 (de)
TW (1) TW562679B (de)
ZA (1) ZA983806B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
TWI246921B (en) * 2000-04-11 2006-01-11 Sankyo Co Stabilized pharmaceutical composition with calcium blocker
HU230253B1 (hu) * 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
JP4633469B2 (ja) * 2002-12-16 2011-02-16 キッセイ薬品工業株式会社 経口固形医薬
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法
CN109985013B (zh) * 2019-05-10 2021-08-10 河北君圣药业有限公司 一种尼群地平分散片及其制备方法
CN115501224A (zh) * 2022-10-09 2022-12-23 南昌大学第一附属医院 马来酸依那普利叶酸片联合通心络在制备治疗高血压合并颈动脉硬化药物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
USH734H (en) * 1988-03-07 1990-02-06 E. R. Squibb & Sons, Inc. Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
JPH01275529A (ja) * 1988-03-21 1989-11-06 E R Squibb & Sons Inc 晩発性運動障害の抑制治療剤
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
SI9300504A (en) * 1993-09-28 1995-04-30 Krka Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
PL326246A1 (en) 1998-11-23
CA2234899C (en) 2004-08-10
SK61698A3 (en) 1998-12-02
EP0884054B9 (de) 2007-02-14
JPH11124330A (ja) 1999-05-11
CN1212869A (zh) 1999-04-07
ES2197443T3 (es) 2004-01-01
BR9805597A (pt) 2000-04-11
AR011730A1 (es) 2000-08-30
JP3576806B2 (ja) 2004-10-13
ES2125198A1 (es) 1999-02-16
NO315545B1 (no) 2003-09-22
ES2125198B1 (es) 1999-11-16
HU9801075D0 (en) 1998-07-28
CA2234899A1 (en) 1998-11-13
EP0884054A2 (de) 1998-12-16
NO982112D0 (no) 1998-05-08
CZ138198A3 (cs) 1998-12-16
TR199800847A2 (xx) 1999-10-21
HUP9801075A2 (hu) 1999-01-28
DE69813083T2 (de) 2004-05-27
PL192117B1 (pl) 2006-09-29
CN1146418C (zh) 2004-04-21
IL124253A (en) 2003-01-12
HUP9801075A3 (en) 2000-12-28
SK284337B6 (sk) 2005-02-04
NO982112L (no) 1998-11-16
EP0884054A3 (de) 2000-08-23
DE69813083D1 (de) 2003-05-15
AU6597398A (en) 1998-11-19
NZ330447A (en) 1998-12-23
TR199800847A3 (tr) 1999-10-21
TW562679B (en) 2003-11-21
PT884054E (pt) 2003-08-29
ZA983806B (en) 1999-02-19
AU735404B2 (en) 2001-07-05
EP0884054B1 (de) 2003-04-09
CZ292616B6 (cs) 2003-11-12
DK0884054T3 (da) 2003-07-21
RU2182002C2 (ru) 2002-05-10

Similar Documents

Publication Publication Date Title
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
ATE527022T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
ATE357440T1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
DE69812603D1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE214274T1 (de) Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60143061D1 (de) Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE279386T1 (de) Retinoide zur behandlung von emphysem
ATE310537T1 (de) Kombinationstherapie von angiotensin- konvertierendem enzymhemmer und epoxy-steroidalem aldosteron antagonist zur behandlung von kardiovaskulären erkrankungen
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE236653T1 (de) Kombination in feste dosiermenge von angiotensin- converting-enzyme-hemmern mit calcium-kanal antagonisten zur behandlung von herz- kreislauferkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE60026644D1 (de) Verwendung von Ferulasäure zur Behandlung von Bluthochdruck

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0884054

Country of ref document: EP

EEIH Change in the person of patent owner